Successful infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in two Taiwanese children: An experience from a medical center

• Chun-Ting Liu,
• G.W. Gant Luxton,
• Chia-Cheng Sung,
• Fu-Min Wang,
• Chia-Ning Chang,
• Chih-Fen Hu

Affiliations

Chun-Ting Liu

Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC

G.W. Gant Luxton

Department of Molecular and Cellular Biology, University of California-Davis, Davis, CA, USA

Chia-Cheng Sung

Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC

Fu-Min Wang

Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC

Chia-Ning Chang

Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC

Chih-Fen Hu

Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC; Corresponding author. Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, No. 325, Cheng-Kung Road, Section 2, Neihu 114, Taipei, Taiwan, ROC.